MENU

Jeffrey M. Farma, MD, FACS

Jeffrey Farma, MD, FACS

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Co-Director, Melanoma and Skin Cancer Program

Chief, Division of General Surgery

Professor, Department of Surgical Oncology 

Program Director, Complex General Surgical Oncology Fellowship

TRDG Member, Colorectal and SI Cancer; Melanoma and Skin Cancer; Sarcoma and GIST Cancer

NCCN, Non-Melanoma Skin Cancer Panel Member

Treatment Focus

Colorectal cancer, melanoma, sarcoma, minimally invasive and robotic surgery, isolated limb infusion for in-transit melanoma and extremity sarcomas.

Research Program

Key Awards

Philadelphia Magazine Top Docs 2020
     Surgery

Treatment Philosophy

It is an honor to be part of the staff of the Fox Chase Cancer Center. My initial exposure occurred during a rotation as a Temple University Medical School student at Fox Chase that led me down the path of Surgical Oncology. As a native Philadelphian, I am privileged to work at such an esteemed institution. I was enthralled then by the dedicated care of the staff in dealing with all aspects of treating patients diagnosed with cancer, and I hope to continue this throughout my career at Fox Chase.

I trained in general surgery at Temple University Hospital. During my fellowship at the National Cancer Institute in Bethesda, Maryland, I learned from experts in the field of surgical oncology about clinical trial design, experimental therapeutics and the importance of bench-to-bedside research to progress the fight against cancer. I encountered patients with very complex problems, and the greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.

My clinical surgical oncology fellowship at the Moffitt Cancer Center in Tampa, Florida has provided me with an extensive understanding of the multidisciplinary approach to treating patients with cancer. One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer. I have developed a particularly strong interest in the surgical and multimodal treatment of patients with Melanoma, Sarcoma and Colorectal cancers, using traditional surgery, regional therapies, and minimally invasive techniques. I have the operative expertise to perform many of these complex procedures using laparoscopic, robotic, and TAMIS (transanal minimally invasive surgery) techniques and have had advanced training in using newest techniques.  I am an expert in the treatment of colorectal cancer including; sphincter sparing and nerve sparing resections, and treating patients with hereditary colorectal cancer syndromes.  

For melanoma and sarcoma that has regional spread in the extremities I offer a minimally invasive technique call Isolated Limb Infusion, and perform minimally invasive inguinal lymph node dissections.

Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients and families goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family m ember.

Follow on Twitter: @jeffreyfarma

Education and Training

Educational Background

  • Fellow, Surgical Oncology, Moffitt Cancer Center, Tampa, FL, 2009
  • Administrative Chief Resident, Department of Surgery, Temple University Hospital, Philadelphia, PA, 2007
  • Chief Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2006
  • Fellow, Surgical Oncology, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD, 2005
  • Resident, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2003
  • MD, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 2000

Certifications

  • American Board of Surgery

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Non-Melanoma Skin Cancer Panel
  • American College of Surgeons
  • American College of Surgeons Oncology Group (ACOSOG)
  • American Radium Society
  • American Society of Colon and Rectal Surgeons
  • Association of Academic Surgery- Candidate Member
  • College of Physicians of Philadelphia
  • Connective Tissue Oncology Society (CTOS)
  • Eastern Cooperative Oncology Group
  • Metropolitan Philadelphia American College of Surgeons
  • Midwest Melanoma Partnership (MMP)
  • North American Neuroendocrine Tumor Society
  • Pennsylvania Medical Society
  • Philadelphia Academy of Surgery
  • Society of Laparoendoscopic Surgeons
  • Society of Surgical Oncology,  vice chair of the Complex General Surgical Oncology Program Directors Committee
  • Society for Surgery of the Alimentary Tract
  • Society of University Surgeon
  • Surgical Biology Club III

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2018-20
  • 2020 AAS/Colombian Surgical Association International Visiting Professorship Award, 2019
  • Society of Surgical Oncology European Society of Surgical Oncology Observership, 2019
  • Castle Connelly national list of Top Doctors®, Regional Top Doctor 2014-17
  • Humanitarian Award, Melanoma Research Foundation, 2016
  • 2015 American College of Surgeons Traveling Fellowship to Germany, 2014
  • Alpha Omega Alpha, National Medical Honor Society, Epsilon Chapter- Honorary Member, 2014
  • H. Lee Moffitt Cancer Center 2008 Fellow’ Education Research Symposium, Best Clinical Poster Presentation, 2008
  • Temple University Surgery Resident Research Symposium Award, 2007
  • H. Taylor Caswell Award, Department of Surgery Teaching Award  for outstanding Chief Surgical Resident, 2007
  • ASCO Foundation Merit Award, 2005
Patient Stories

Michelle Palandro

Sarcoma

Michelle Palandro

Sarcoma

Michelle Palandro was a healthy and active 27-year-old woman when she was diagnosed with liposarcoma. After first meeting with an oncologist at a large teaching hospital, Michelle was not convinced that this was the best place for her treatment. She sought a second opinion and was pleased with the compassion and thoroughness of the treatment team at Fox Chase. After undergoing surgery, chemotherapy, and radiation therapy, Michelle is happy to report that she has been cancer free since 2012, and that she gave birth to a healthy baby boy in 2015. "At Fox Chase, every single person I met and every single nurse who took care of me was exceptional."

Mary Marczely

Sarcoma

Mary Marczely

Sarcoma

At each of the 13 races she's run since 2010, Mary Marczely always races to cross the finish line. The contest that meant the most to her was the race against the cancer she was diagnosed with in August 2010.

Mary, a busy mother of two sons, who were age two and four at the time of her diagnosis, started experiencing an odd tingling sensation in her left calf and foot.  The discomfort grew into pain and numbness. 

Kathleen Marchek

Breast Cancer;  Colorectal Cancer

Kathleen Marchek

Breast Cancer;  Colorectal Cancer

One cancer diagnosis is bad enough. Two in the same month is really over the top. But that’s exactly what I faced in August 2009 at the age of 54. I was a teacher at the time and was very involved in an afterschool program called Read to Succeed. Our daughter had just graduated from Penn State in May of 2009 and was planning to move home until she found employment.

Carol Kalinich

GIST (Gastrointestinal Stromal Tumor)

Carol Kalinich

GIST (Gastrointestinal Stromal Tumor)

"On October 29, 2012, I thought I had a bad case of the flu. I had slight pains on the right side and was really tired. I decided to go to the local hospital for a checkup and that’s when everything in my world started to change. I ended up with emergency surgery that day for an appendectomy. Afterwards my surgeon, Dr. Carlos Villarreal, and my best friend, Dr. Richard Bindie, told me that if I had waited a couple more hours I would have been dead. Dr.

Robert Smith

Sarcoma

Robert Smith

Sarcoma

I have battled sarcoma several times over the past 20 years. The first time was in 1998 when I was 54 and felt a lump on the side of my torso. Doctors at a community hospital ordered some tests that confirmed the diagnosis of fibrous spindle cell sarcoma. I was given 30 rounds of chemotherapy and continued under the medical supervision of my oncologist for 3 years.

Pages

Research Profile

Research Program

Research Interests

  • Melanoma: Molecular profiling, outcomes research, clinical trials, immunotherapy
  • Colorectal: Molecular and imaging profiling for rectal cancer, outcomes research, clinical trials, quality of life
  • Sarcoma
Publications

Selected Publications

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. Annals of surgical oncology, 2019. PubMed

Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery? Journal of Surgical Research, 231:242-7, 2018. 

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbrook BJ, Bilimoria KY, Jake Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. Journal of the American College of Surgeons. November 2015.

Schatz TP, Nassif MO, Farma JM. Extensive portal venous gas: Unlikely etiology and outcome. Int J Surg Case Rep. December 2014.

Yeo H, Niland J, Milne D, ter Veer A, Bekail-Saab T, Farma JM,  Lai L,  Skibber JM,  Small W Jr,  Wilkinson N, Schrag D, Weiser MR, Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers. Journal of the National Cancer Institute. December 2014.

Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in Treatment of Angiosarcoma: A Single Institution Experience. The American Journal of Surgery. April 2014.

Johnson ME, Zhu F, Li T, Wu H, Galloway TJ, Farma JM,. Perlis C Turaka A,. Absolute Lymphocyte Count: a Potential Prognostic Factor for Merkel Cell Carcinoma.  Journal of the American Academy of Dermatology. March 2014.

Yeo H, Niland J, Milne D, Veer AT, Bekaii-Saab T, Farma JM, Lai L, Skibber J, Small W, Wilkenson N, Schrag D, Weiser M. Incidence of Minimally Invasive Colorectal Cancer Surgery at National Comprehensive Cancer Network Centers. Journal of the National Cancer Institute. Accepted for publication. January 2014.

Keller D, Thomay AA, Gaughan J, Wu H, Farma JM. Outcomes in Patients with Mucosal Melanomas. Journal of Surgical Oncology. October 2013.

Chen KT, Papavasiliou P, Edwards K, Zhu F, Perlis C, Wu H, Turaka A, Berger A, Farma JM. A better prognosis for merkel cell carcinoma of unknown primary origin. American Journal of Surgery. July 2013.

Arrangoiz R, Papavasiliou P, Siripuapu V, Li T, Watson JC, Hoffman JP, Farma JM, Partial stomach-partitioning gastrojejunostomy as an alternative for palliation in patients with malignant gastric or duodenal outlet obstruction. American Journal of Surgery. May 2013.

Nitzkorski, James, Willis, A, Farma JM, Zhu F, Nick D, Sigurdson, E. Association of race and socioeconomic status and outcomes with patients with rectal cancer. Ann Surg Oncol. January 2013.

Chen KT, Olszanski A, Farma JM. Donor transmission of melanoma following renal transplant. Case Reports in Transplantation. November 2012.

Farma JM, Zager JS, Barnica-elvir V, Puleo CA, Marzban SS, Rollison DE, Messina JL, Sondak VK. A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol. November 2012.

Additional Publications

Dr. Jeffery Farma on PubMed

Ratings

174 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.9 / 5.0

RATINGS BREAKDOWN

  • 4.8
  • 4.9
  • 4.9
  • 5.0
  • 4.8

10 PATIENT COMMENTS

  • 5.0
    September 12, 2019
    Dr. Farma is wonderful.
  • 5.0
    September 09, 2019
    always excellent
  • 5.0
    September 05, 2019
    Dr. FARMA is the best!! And his staff.
  • 5.0
    August 17, 2019
    Referred by PCP for special care.. Am very impressed with coordination and ease of process from seeing specialist to setting up needed surgery. Everyone went out of their way to get things done in a timely manner yet taking time to answer any questions and providing information about and scheduling surgery.
  • 5.0
    July 31, 2019
    Dr. Farma is an accomplished, friendly and caring physician.
  • 5.0
    July 28, 2019
    i have had a great experience with Dr. Farma's office and Fox Chase in general. Dr. Farma took his time to explain everything to me and even called me on a Friday night to explain something that came about with a biopsy. I have a lot of respect for him and would recommend him and Fox Chase to everyone.
  • 4.5
    July 24, 2019
    [...] he is an exceptional doctor.
  • 5.0
    July 07, 2019
    Dr. Farma is extremely hospitable and listens.
  • 5.0
    June 30, 2019
    FCCC is a very good hospital. Staff is very professional. Dr. Farma is very professional.
  • 5.0
    June 30, 2019
    visit excellent
LOAD MORE

Connect with Fox Chase